<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6720359\results\search\disease\results.xml">
  <result pre="provided the original work is properly cited. Abstract Background Yearly" exact="influenza" post="epidemics have considerable effects on public health worldwide. The"/>
  <result pre="epidemics have considerable effects on public health worldwide. The 2017-2018" exact="influenza" post="season in Italy was of greater severity than previous"/>
  <result pre="The aim of this study was to describe the 2017-2018" exact="influenza" post="season in Southern Italy and the molecular characteristics of"/>
  <result pre="from week 46/2017 to week 17/2018 were tested to identify" exact="influenza" post="A viruses (IAV) and influenza B viruses (IBV). Sequencing"/>
  <result pre="17/2018 were tested to identify influenza A viruses (IAV) and" exact="influenza" post="B viruses (IBV). Sequencing and phylogenetic analysis of haemagglutinin"/>
  <result pre="Intensive-care unit (ICU) admission was required in 50 cases of" exact="acute respiratory distress syndrome" post="(ARDS). Among the &amp;gt;64-year age group, 18 out of"/>
  <result pre="14 of these (77.8%) were B/Yamagata lineage. Conclusions The 2017-2018" exact="influenza" post="season was one of the most severe in a"/>
  <result pre="suggests that further data on the effectiveness of the available" exact="influenza" post="vaccines are needed to determine the best way to"/>
  <result pre="protect the elderly against both IBV lineages. 1. Introduction Yearly" exact="influenza" post="epidemics have severe effects on public health worldwide. Influenza"/>
  <result pre="in children [2]. Every year, 3â€&quot;5 million cases of severe" exact="influenza" post="and around 290,000â€&quot;650,000 influenza-related deaths occur [3]. Vaccination is"/>
  <result pre="occur [3]. Vaccination is the most effective way to prevent" exact="influenza" post="virus infection and its complications. However, because of antigenic"/>
  <result pre="and its complications. However, because of antigenic drift in seasonal" exact="influenza" post="viruses, the composition of the vaccines must be changed"/>
  <result pre="In Italy, the recommendations for the use of the available" exact="influenza" post="vaccines are reported yearly in a document of the"/>
  <result pre="a document of the Ministry of Health. For the 2017-2018" exact="influenza" post="season, for the northern hemisphere, the recommended vaccine formulation"/>
  <result pre="acute respiratory infections (ARIs) to the national focal point for" exact="influenza" post="surveillance [6]. From week 40 of one year to"/>
  <result pre="(epidemiological surveillance) and collect respiratory specimens to identify the circulating" exact="influenza" post="strains (virological surveillance) [7]. In Italy, the estimated incidence"/>
  <result pre="strains (virological surveillance) [7]. In Italy, the estimated incidence of" exact="influenza" post="in the 2017-2018 season was &amp;gt;8.5 million [8], which"/>
  <result pre="in the week 02/2018 [8]. Some 60% of all laboratory-confirmed" exact="influenza" post="cases were caused by influenza B virus (IBV) [9]."/>
  <result pre="Some 60% of all laboratory-confirmed influenza cases were caused by" exact="influenza" post="B virus (IBV) [9]. No recent data are available"/>
  <result pre="[9]. No recent data are available on the epidemiology of" exact="influenza" post="and on the circulation of influenza viruses during recent"/>
  <result pre="on the epidemiology of influenza and on the circulation of" exact="influenza" post="viruses during recent seasons in Southern Italy. The aim"/>
  <result pre="The aim of this study was to describe the 2017-2018" exact="influenza" post="season in the Apulia region (Southern Italy), along with"/>
  <result pre="&amp;gt;4 million people. According to the national protocol, the regional" exact="influenza" post="surveillance system surveys about 2% of the general population"/>
  <result pre="least one of three respiratory symptoms (cough, sore throat, and" exact="shortness" post="of breath) [10]. For epidemiological purposes, the number of"/>
  <result pre="sign or symptom of acute respiratory illness (cough, sore throat," exact="shortness" post="of breath, and coryza) [10], and from patients admitted"/>
  <result pre="admitted to all intensive-care units (ICUs) of the region with" exact="acute respiratory distress syndrome" post="(ARDS), during the influenza season. All the samples were"/>
  <result pre="the region with acute respiratory distress syndrome (ARDS), during the" exact="influenza" post="season. All the samples were analysed at the Laboratory"/>
  <result pre="(Anyplex RV16 Detection; Seegene, Seoul, Republic of Korea). Subtyping of" exact="influenza" post="A virus (IAV) was performed with a commercial real-time"/>
  <result pre="from patients with SARI, and 14 from ICU-ARDS), 36 were" exact="influenza" post="A/H1N1pdm09 (five from individuals with ILIs, 10 from patients"/>
  <result pre="patients with SARI, and 21 from ICU-ARDS), and two were" exact="influenza" post="A/H3N2 (one from a patient with SARI and one"/>
  <result pre="that already deposited. 3. Results In Apulia, during the 2017-2018" exact="influenza" post="season, the first two sporadic cases were identified in"/>
  <result pre="week 9/2018. A total of 2,175 patients was tested for" exact="influenza" post="viruses, and 565 (26.0%) were positive. IBV strains were"/>
  <result pre="50 individuals, 8 of whom were vaccinated for the 2017-2018" exact="influenza" post="season, and all but 3 of whom had comorbidities."/>
  <result pre="age group, in which 12 of the 50 individuals with" exact="influenza" post="(24.0%) had ICU-ARDS, whereas no children &amp;lt;15 years old"/>
  <result pre="3 shows the distribution of the number of cases of" exact="influenza" post="by age group and type of virus identified for"/>
  <result pre="the 15â€&quot;49-year and 50â€&quot;64-year age groups was mostly associated with" exact="influenza" post="A/H1N1pdm09 infection, whereas among the 65â€&quot;74-year and &amp;gt;74-year age"/>
  <result pre="IBV infection was significantly more frequent in patients with severe" exact="influenza" post="(ICU-ARDS and SARI cases) compared to sentinel patients (ILI"/>
  <result pre="more frequent in ILI cases compared to patients with severe" exact="influenza" post="(p&amp;lt;0.0001), whereas no significant difference was found for the"/>
  <result pre="genes of the 35 IBV strains characterised during the 2017-2018" exact="influenza" post="season (Figure 4) showed that all of the B/Yamagata"/>
  <result pre="season in the northern hemisphere). 4. Discussion The monitoring of" exact="influenza" post="epidemiology and disease and the characterisation of circulating strain"/>
  <result pre="provide data to public-health authorities to facilitate the management of" exact="influenza" post="epidemics and the planning of control measures. In Apulia,"/>
  <result pre="In Apulia, as in the rest of Italy, the 2017-2018" exact="influenza" post="season had one of the greatest impacts on public"/>
  <result pre="fell, and infection with A/H1N1pdm09 became predominant. The proportion of" exact="influenza" post="infections resulting from IBV was higher in Apulia than"/>
  <result pre="Italy as a whole (71.0% versus 60.0%) [9]. The 2017-2018" exact="influenza" post="season was characterised by an IBV lineage mismatch with"/>
  <result pre="the lineage mismatch contributed to the severe impact of the" exact="influenza" post="epidemic. Notably, all of the characterised B/Yamagata strains belonged"/>
  <result pre="the impact of IBV in the elderly in the 2017-2018" exact="influenza" post="season, the Italian Ministry of Health has also recommended,"/>
  <result pre="at low risk (without multiple comorbidities) [24]. The use of" exact="influenza" post="vaccines in those &amp;gt;64 years old is under debate"/>
  <result pre="[30â€&quot;34]. Further evidence of the relative effectiveness of the different" exact="influenza" post="vaccines in the elderly is needed for definitive recommendations"/>
  <result pre="In conclusion, our data provide information on the most recent" exact="influenza" post="season and on the molecular epidemiology of the circulating"/>
  <result pre="influenza season and on the molecular epidemiology of the circulating" exact="influenza" post="viruses in Apulia, a densely populated region of Italy."/>
  <result pre="virological surveillance remain an essential tool for monitoring of the" exact="influenza" post="season and the characteristics of circulating viruses, to identify"/>
  <result pre="and Jolanda Prisco for invaluable help in collecting data on" exact="influenza" post="cases and on ICU-ARDS. Abbreviations ARDS: Acute respiratory distress"/>
  <result pre="respiratory distress syndrome ARI: Acute respiratory infection aTIV: Adjuvanted trivalent" exact="influenza" post="vaccine IAV: Influenza A virus IBV: Influenza B virus"/>
  <result pre="IBV: Influenza B virus ILI: Influenza-like illness ICU-ARDS: Case of" exact="influenza" post="infection with ARDS requiring admission to an intensive-care unit"/>
  <result pre="with ARDS requiring admission to an intensive-care unit QIV: Quadrivalent" exact="influenza" post="vaccine SARI: Severe acute respiratory infection TIV: Trivalent influenza"/>
  <result pre="Quadrivalent influenza vaccine SARI: Severe acute respiratory infection TIV: Trivalent" exact="influenza" post="vaccine. Data Availability The data that support the findings"/>
  <result pre="Fact Sheets Influenza (Seasonal). http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) 4Ministry of Health. Recommendations for" exact="influenza" post="prevention and control, 2017-2018 season, Italy. http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2017&amp;amp;codLeg=60180&amp;amp;parte=1%20&amp;amp;serie=null 5World Health"/>
  <result pre="â€&quot; Operating protocol for epidemiological and virological surveillance - 2017-2018" exact="influenza" post="season. http://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua=italiano&amp;amp;id=2649 8InfluNet - Epidemiological report, week 17/2018. http://www.salute.gov.it/portale/temi/documenti/epidemiologica/Influnet_2018_17.pdf"/>
  <result pre="Health Organization (WHO). WHO information for the molecular detection of" exact="influenza" post="viruses. July 2017. https://www.who.int/influenza/gisrs_laboratory/WHO_information_for_the_molecular_detection_of_influenza_viruses_20171023_Final.pdf?ua=1 12VegaT.LozanoJ. E.MeerhoffT.et al.Influenza surveillance in"/>
  <result pre="HemagglutininJournal of Virology20088263011302010.1128/JVI.02477-0718184701 15World Health Organization (WHO). Recommended composition of" exact="influenza" post="virus vaccines for use in the 2017- 2018 northern"/>
  <result pre="virus vaccines for use in the 2017- 2018 northern hemisphere" exact="influenza" post="season. March 2017. https://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf?ua=1 16RondyM.KisslingE.EmborgH.et al.Interim 2017/18 influenza seasonal"/>
  <result pre="northern hemisphere influenza season. March 2017. https://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf?ua=1 16RondyM.KisslingE.EmborgH.et al.Interim 2017/18" exact="influenza" post="seasonal vaccine effectiveness: combined results from five European studiesEurosurveillance201823910.2807/1560-7917.ES.2018.23.9.18-00086"/>
  <result pre="of D222G amino acid substitution in the haemagglutinin of pandemic" exact="influenza" post="A (H1N1) 2009 viruses. Wkly Epidemiol Rec. 2010 Jan"/>
  <result pre="Epidemiol Rec. 2010 Jan 22;85(4):21-2 19RykkvinR.KilanderA.DudmanS. G.HungnesO.Within-patient emergence of the" exact="influenza" post="A(H1N1)pdm09 HA1 222G variant and clear association with severe"/>
  <result pre="virus receptors in the human airwayNature2006440708343543610.1038/440435a16554799 22Flu News Italy. Integrated" exact="influenza" post="surveillance report, 2017/2018 influenza season. http://www.salute.gov.it/portale/influenza/documenti/flunews/FluNews_2018_13.pdf 23Ministry of Health."/>
  <result pre="human airwayNature2006440708343543610.1038/440435a16554799 22Flu News Italy. Integrated influenza surveillance report, 2017/2018" exact="influenza" post="season. http://www.salute.gov.it/portale/influenza/documenti/flunews/FluNews_2018_13.pdf 23Ministry of Health. Recommendations for influenza prevention"/>
  <result pre="report, 2017/2018 influenza season. http://www.salute.gov.it/portale/influenza/documenti/flunews/FluNews_2018_13.pdf 23Ministry of Health. Recommendations for" exact="influenza" post="prevention and control, 2018-2019 season, Italy. http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2018&amp;amp;codLeg=64381&amp;amp;parte=1%20&amp;amp;serie=null 24Apulia region."/>
  <result pre="region. Nota n. 4571, 16.10.2017. â€œMinistry of Health, Recommendations for" exact="influenza" post="prevention and control, 2017-2018 season, Italy. Notification.â€� https://www.sanita.puglia.it/documents/36044/41587901/Circolare+regionale/62a1ca12-38de-4dde-9944-e97f04a84dea 25BarbieriM.CapriS.WaureC."/>
  <result pre="D. E.BoccaliniS.PanattoD.Age- and risk-related appropriateness of the use of available" exact="influenza" post="vaccines in the Italian elderly population is advantageous: Results"/>
  <result pre="Hygiene2017584E279E28729707658 26MenniniF. S.BiniC.MarcellusiA.RinaldiA.FrancoE.Cost-effectiveness of switching from trivalent to quadrivalent inactivated" exact="influenza" post="vaccines for the at-risk population in ItalyHuman Vaccines &amp;amp;"/>
  <result pre="&amp;amp; Immunotherapeutics20181481867187310.1080/21645515.2018.146936829708843 27MontomoliE.TorelliA.ManiniI.GianchecchiE.Immunogenicity and safety of the new inactivated quadrivalent" exact="influenza" post="vaccine vaxigrip tetra: Preliminary results in children â‰¥6 months"/>
  <result pre="months and older adultsVaccines201861 28CapriS.BarbieriM.de WaureC.BoccaliniS.PanattoD.Cost-effectiveness analysis of different seasonal" exact="influenza" post="vaccines in the elderly Italian populationHuman Vaccines &amp;amp; Immunotherapeutics20181461331134110.1080/21645515.2018.143879229425079"/>
  <result pre="the elderly Italian populationHuman Vaccines &amp;amp; Immunotherapeutics20181461331134110.1080/21645515.2018.143879229425079 29de WaureC.BoccaliniS.BonanniP.et al.Adjuvanted" exact="influenza" post="vaccine for the Italian elderly in the 2018/19 season:"/>
  <result pre="during 2016â€&quot;2017 seasonClinical Infectious Diseases2018 31CastillaJ.NavascuÃ©sA.CasadoI.et al.Interim effectiveness of trivalent" exact="influenza" post="vaccine in a season dominated by lineage mismatched influenza"/>
  <result pre="trivalent influenza vaccine in a season dominated by lineage mismatched" exact="influenza" post="B, northern Spain, 2017/18Eurosurveillance201823710.2807/1560-7917.ES.2018.23.7.18-00057 32CamilloniB.NeriM.LepriE.IorioA. M.Cross-reactive antibodies in middle-aged"/>
  <result pre="antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent" exact="influenza" post="vaccine against B viruses of the B/Victoria or B/Yamagata"/>
  <result pre="33RayR.Dos SantosG.BuckP. O.et al.A review of the value of quadrivalent" exact="influenza" post="vaccines and their potential contribution to influenza controlHuman Vaccines"/>
  <result pre="value of quadrivalent influenza vaccines and their potential contribution to" exact="influenza" post="controlHuman Vaccines &amp;amp; Immunotherapeutics20171371640165210.1080/21645515.2017.131337528532276 34SkowronskiD. M.ChambersC.De SerresG.et al.Vaccine effectiveness"/>
  <result pre="34SkowronskiD. M.ChambersC.De SerresG.et al.Vaccine effectiveness against lineage matched and mismatched" exact="influenza" post="B viruses across 8 seasons in Canada, 2010-11 to"/>
  <result pre="1 Distribution of samples according to type or subtype of" exact="influenza" post="virus identified and incidence of influenza-like illness (ILI) in"/>
  <result pre="in each week of surveillance in Apulia in the 2017-2018" exact="influenza" post="season. Figure 2 Distribution of influenza-positive cases by age"/>
  <result pre="and type of virus identified, in Apulia in the 2017-2018" exact="influenza" post="season. Figure 3 Distribution of the number of cases"/>
  <result pre="season. Figure 3 Distribution of the number of cases of" exact="influenza" post="infection with ARDS requiring admission to an intensive-care unit"/>
  <result pre="and type of virus identified, in Apulia in the 2017-2018" exact="influenza" post="season. Figure 4 Phylogenetic analysis of the haemagglutinin (HA)"/>
  <result pre="influenza-like illness; SARI, severe acute respiratory illness; ICU-ARDS, cases with" exact="acute respiratory distress syndrome" post="requiring admission to an intensive-care unit) and, if vaccinated,"/>
  <result pre="influenza-like illness; SARI, severe acute respiratory illness; ICU-ARDS, cases with" exact="acute respiratory distress syndrome" post="requiring admission to an intensive-care unit) and, if vaccinated,"/>
 </snippets>
</snippetsTree>
